In October 1 Journal of Clinical Investigation, Tomohiro Osanai and colleagues from Hirosaki University School of Medicine, Hirosaki, Japan show that mitochondrial CF6 is also a potent circulating ...

In pulmonary hypertension, a combination of metabolic and mechanical dysfunction leads to irreversible vascular damage.

In April 2025, Actelion announced a study is to demonstrate superiority of macitentan 75 milligrams (mg) in prolonging the ...

In high-risk patients with pulmonary arterial hypertension, Merck ’s fusion protein therapeutic Winrevair reduced the ...